ArticleBMC infectious diseases2025
Hepatitis B vaccination status, knowledge and associated factors among healthcare professionals in Dongola, Sudan, 2024: a cross-sectional study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hepatitis B Vaccination Coverage and Associated Factors Among Healthcare Workers: A Cross-Sectional Study.Health science reports · 2026Article
- Uptake and determinants of Hepatitis B vaccination among health laboratory practitioners in tertiary hospitals in Dar es Salaam, Tanzania: A cross-sectional study.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHepatitis B virus (HBV) infection remains a significant global health concern, with 254 million people chronically infected worldwide and 1.1 million annual deaths from related complications. Healthcare professionals (HCPs) face an elevated risk of HBV infection due to occupational exposure, with a global prevalence of 2.3% among HCPs, increasing to 6.8% in Africa. Vaccination is the most effective preventive measure against HBV, yet coverage remains suboptimal, particularly in developing countries, including Sudan.
objectiveThis study aimed to assess HBV vaccination status, knowledge and associated factors among HCPs in Dongola, Sudan.
methodsA cross-sectional study was conducted among HCPs in two hospitals in Dongola, Sudan, from May to July 2024. The sample size was calculated as 206 using OpenEpi, based on a 50% estimated vaccination proportion, 95% confidence level, and 5% margin of error, and adjusted by 10% for nonresponse. Participants were recruited via stratified random sampling. Data were collected through a structured and pre-tested questionnaire assessing socio-demographic characteristics, HBV knowledge, and vaccination status. HBV knowledge was evaluated via 21 items, with scores ≥ 13 classified as “good knowledge”. Descriptive statistics summarised participant characteristics, vaccination status and HBV knowledge. Factors associated with HBV vaccination status were assessed via logistic regression analyses.
resultsAmong the 227 HCPs, 211 participated in the study. The majority were under 30 years old (84.83%), female (70.62%), and had less than 5 years of work experience (65.40%). A total of 52.13% reported being vaccinated against HBV, with 65.45% of those receiving all three recommended doses. Notably, vaccine unavailability was reported by 93.84% of the participants. In terms of HBV knowledge, 62.09% were classified as having good knowledge about HBV. In the adjusted analysis, factors significantly associated with higher vaccination rates included more work experience (5–10 years: aOR 2.60, 95% CI 1.24–5.43; >10 years: aOR 4.16, 95% CI 1.08–16.05) and greater HBV knowledge (aOR 2.72, 95% CI 1.48–5.01). However, laboratory technologists had lower odds of vaccination than doctors (aOR 0.19, 95% CI 0.07–0.56).
conclusionThis study revealed suboptimal HBV vaccination coverage among HCPs, with only 34.12% being fully vaccinated. Key barriers included vaccine unavailability, whereas longer work experience and greater HBV knowledge were positively associated with vaccination status. These findings emphasise the need for comprehensive interventions to improve vaccine accessibility, enhance HBV education, and implement mandatory vaccination policies in healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.